Cargando…

Phase I/II Trial of Ruxolitinib in Combination with Trastuzumab in Metastatic HER2 Positive Breast Cancer

PURPOSE: Preclinical data demonstrate STAT3 as an important regular in HER2+ tumors, and disruption of the IL6-JAK2-STAT-S100A8/S100A9 signaling cascade reduces HER2+ cell viability. Ruxolitinib is an FDA approved inhibitor of JAK1 and JAK2. We performed a phase I/II trial investigating the safety a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kearney, Matthew, Franks, Lauren, Lee, Shing, Tiersten, Amy, Makower, Della F, Cigler, Tessa, Mundi, Prabhjot, Chi, Dow-Chung, Goel, Anupama, Klein, Pam, Andreopoulou, Eleni, Sparano, Joseph, Trivedi, Meghna, Accordino, Melissa, Califano, Andrea, Hershman, Dawn L, Silva, Jose, Kalinsky, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487317/ https://www.ncbi.nlm.nih.gov/pubmed/34169393 http://dx.doi.org/10.1007/s10549-021-06306-4

Ejemplares similares

Characteristics and outcomes of patients with breast cancer diagnosed with SARS-Cov-2 infection at an academic center in New York City
por: Kalinsky, Kevin, et al.
Publicado: (2020)

Randomized phase II trial of fulvestrant alone or in combination with bortezomib in hormone receptor-positive metastatic breast cancer resistant to aromatase inhibitors: a New York Cancer Consortium trial
por: Adelson, Kerin, et al.
Publicado: (2016)

Effects of neoadjuvant chemotherapy on the contralateral non-tumor-bearing breast assessed by diffuse optical tomography
por: Altoe, Mirella L., et al.
Publicado: (2021)

An emerging generation of endocrine therapies in breast cancer: a clinical perspective
por: Patel, Rima, et al.
Publicado: (2023)

Identifying Predictors of Taxane-Induced Peripheral Neuropathy Using Mass Spectrometry-Based Proteomics Technology
por: Chen, Emily I., et al.
Publicado: (2015)

Progress in adjuvant chemotherapy for breast cancer: an overview
por: Anampa, Jesus, et al.
Publicado: (2015)

The clinical utility of gene expression assays in breast cancer patients with 0–3 involved lymph nodes
por: Barbi, Mali, et al.
Publicado: (2021)

Florid Pulmonary Mycobacterium avium-intracellulare Infection in a Patient With Large Granular Lymphocytic (LGL) Leukemia on Chronic Cyclophosphamide
por: Kojadinovic, Arsenije, et al.
Publicado: (2021)

Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer
por: Marks, Douglas K., et al.
Publicado: (2020)

Lymphovascular invasion, race, and the 21-gene recurrence score in early estrogen receptor-positive breast cancer
por: Makower, Della, et al.
Publicado: (2021)

Documentation of Complete Response in Metastatic Breast Cancer to Liver and Bone Achieved with Trastuzumab and Pegylated Liposomal Doxorubicin
por: Kobrinsky, Boris, et al.
Publicado: (2008)

Ruxolitinib for myelofibrosis
por: GU, LIAN, et al.
Publicado: (2013)

Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity
por: Stanton, Sasha E, et al.
Publicado: (2015)

The 21-gene recurrence score in early non-ductal breast cancer: a National Cancer Database analysis
por: Makower, Della, et al.
Publicado: (2022)

Ruxolitinib: Thrombocytopenia following compassionate use of ruxolitinib: 2 case reports
Publicado: (2022)

Extranodal Diffuse Large B-Cell Lymphoma of Bone and Soft Tissue Presenting With Marked Lymphedema and Hypercalcemia
por: Shabbir, Arafat, et al.
Publicado: (2022)

Ruxolitinib for essential thrombocythemia?
por: Bose, Prithviraj, et al.
Publicado: (2017)

Eribulin mesylate in the treatment of metastatic breast cancer
por: Jain, Sarika, et al.
Publicado: (2012)

Ruxolitinib in Myelofibrosis and Polycythemia Vera
por: Wolfe, Leah
Publicado: (2016)

Ruxolitinib in myelofibrosis: to be or not to be an immune disruptor
por: Manduzio, Palma
Publicado: (2017)

Coccidioidomycosis in Patients Treated With Ruxolitinib
por: Kusne, Yael, et al.
Publicado: (2020)

Ruxolitinib for the Treatment of Essential Thrombocythemia
por: Gunawan, Arief, et al.
Publicado: (2018)

Ruxolitinib and Severe COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Efficacy of ruxolitinib on hepatomegaly in patients with myelofibrosis
por: Verstovsek, S, et al.
Publicado: (2016)

Ruxolitinib therapy and telomere length in myelofibrosis
por: Caocci, G, et al.
Publicado: (2016)

Management of myelofibrosis after ruxolitinib failure
por: Harrison, Claire N, et al.
Publicado: (2020)

Ruxolitinib withdrawal due to the COVID-19
por: Lucijanic, Marko, et al.
Publicado: (2021)

Ruxolitinib: Extreme thrombocytosis: case report
Publicado: (2021)

Pharmacokinetics and Pharmacodynamics of Ruxolitinib: A Review
por: Appeldoorn, T. Y. J., et al.
Publicado: (2023)

Topical ruxolitinib for the treatment of granuloma faciale
por: Wong, Alan, et al.
Publicado: (2023)

Ruxolitinib cream for the treatment of cutaneous sarcoidosis
por: Smith, Jeffrey S., et al.
Publicado: (2023)

Pharmacokinetics of Ruxolitinib in Patients with Atopic Dermatitis Treated With Ruxolitinib Cream: Data from Phase II and III Studies
por: Gong, Xiaohua, et al.
Publicado: (2021)

ODP093 Hunt for Hypercalcemia
por: Wang, Ally W, et al.
Publicado: (2022)

A development of the equations of electromagnetism in material continua
por: Tiersten, Harry F
Publicado: (1990)

Linear piezoelectric plate vibrations: elements of the linear theory of piezoelectricity and the vibrations piezoelectric plates
por: Tiersten, H F
Publicado: (1969)

Ruxolitinib for the treatment of myelofibrosis: its clinical potential
por: Ostojic, Alen, et al.
Publicado: (2012)

Definition and management of ruxolitinib treatment failure in myelofibrosis
por: Pardanani, A, et al.
Publicado: (2014)

Ruxolitinib for Therapy of Graft-versus-Host Disease
por: Neumann, Thomas, et al.
Publicado: (2019)

Delayed granulomatous eruption of the nose associated with ruxolitinib
por: Brown, Margaret, et al.
Publicado: (2020)

Ruxolitinib: Viral respiratory infections: case report
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nsgbt38couqs5o0rodmvpgubim